Skip to main content
Gabriel Brooks, MD, Cardiology, San Francisco, CA

Gabriel C Brooks MD MAS FACC

Non-Invasive Cardiology


Executive Director, Head of Rare Cardiology, Rare Disease Research Unit, Pfizer Inc.

Join to View Full Profile
  • 130 Lawton STSan Francisco, CA 94122

  • Phone+1 510-603-9193

Dr. Brooks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California
    University of CaliforniaMAS, Clinical Research (Epi/Bio-Stats), 2013 - 2015
  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Cardiovascular Disease, 2011 - 2014
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2008
  • Carnegie Mellon University
    Carnegie Mellon UniversityB.S., Biology, 1995 - 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2027
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Scholar Mayo Clinic Cardiovascular Board Review, 2013

Publications & Presentations

PubMed

Journal Articles

  • Evaluation of myocardial fibrosis by post gadolinium T1 measurement in patients with pulmonary hypertension  
    Kallianos K, Higgins C, Odrovas K, J Cardiovasc Magn Reson, 1/1/2015
  • Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus  
    Liu TC, Wang Y, Hallden G, Francis J, Lemoine NR, Kirn D., Gene Ther., 1/1/2005
  • Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer  
    Thorne SH, Lee YL, Au T, Eng LF, Reid T., J Virol, 1/1/2005
  • Join now to see all

Abstracts/Posters

  • The Association Between Clinical and Echocardiographic Imaging Findings and T2 in End Stage Liver Disease
    Brown K, Mehta N, Rubin N, Foster E, Qasim A., American Heart Association, 1/1/2015
  • Evaluation of myocardial fibrosis by post gadolinium T1 measurement in patients with pulmonary hypertension
    Kallianos K, Higgins C, Ordovas K., Society for Cardiac Magnetic Resonance, Nice, 1/1/2015
  • Diagnostic Accuracy of a Smartphone based Six-Minute Walk Test
    Vittinghoff E, Sivaraman I, Marcus G, Olgin J, American Heart Association, 1/1/2014
  • Join now to see all

Lectures

  • Classifying lung cancer stage from health care claims with a clinical algorithm or a machine-learning approach. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • FDA Clears Solid Biosciences Neurodegeneration Gene Therapy IND
    FDA Clears Solid Biosciences Neurodegeneration Gene Therapy INDJanuary 13th, 2025
  • International Update on Fabry Disease and Provides Clinical Update
    International Update on Fabry Disease and Provides Clinical UpdateMay 30th, 2019

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: